In this regard, bGH transgenic mice, which develop spontaneous neoplasms at a higher rate than WT mice [74], also have markedly lower glycine levels than their WT counterparts, while the reverse is observed in GHR-knockout (GHRKO) mice, which are protected from cancer [75]. This evidence concerns the gene GHR and cancer.